AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8636761 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg TNF, IFN (0.2 mg), melphalan (10 mg/L limb volume)
Number of subjects: 38
Study 8636761 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg TNF, IFN (0.2 mg), melphalan (10 mg/L limb volume)
Number of subjects: 38
Study 8636761 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg TNF
Number of subjects: 38
Study 8636761 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg TNF
Number of subjects: 38
Study 1346121 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to reduce alcohol consumption
Number of subjects: 41
Study 1346121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no advice)
Number of subjects: 41
Study 3873661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrode size 3 x 3 cm
Number of subjects: 14
Study 3873661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrode size 6 x 6 cm
Number of subjects: 14
Study 3873661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrode size 9 x 9 cm
Number of subjects: 14
Study 3873661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrode size 5 x 16.2 cm
Number of subjects: 14
Study 3873661 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger electrodes (6 x 6 cm and 9 x 9 cm)
Number of subjects: 14
Study 3873661 — intervention group
Group type: EXPERIMENTAL
Intervention: All electrode sizes
Number of subjects: 14
Study 30392472 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate counting (Intervention Group)
Number of subjects: 286
Study 30392472 — intervention group
Group type: COMPARATOR
Intervention: Traditional nutritional advice (Control Group)
Number of subjects: 286
Study 29884212 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAMS training (8-week program)
Number of subjects: 67
Study 29884212 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 67
Study 29884212 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAMS training
Number of subjects: 67
Study 27604504 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal supportive care (OSC) plus whole brain radiotherapy (WBRT) (20 Gy in five daily fractions)
Number of subjects: 538
Study 27604504 — intervention group
Group type: COMPARATOR
Intervention: Optimal supportive care (OSC) alone
Number of subjects: 538
Study 27604504 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (OSC plus WBRT and OSC alone)
Number of subjects: 538
Study 27604504 — intervention group
Group type: EXPERIMENTAL
Intervention: OSC plus WBRT
Number of subjects: 538
Study 27604504 — intervention group
Group type: COMPARATOR
Intervention: OSC alone
Number of subjects: 538
Study 24606627 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote examiner (RE)
Number of subjects: 40
Study 24606627 — intervention group
Group type: COMPARATOR
Intervention: Local examiner (LE)
Number of subjects: 40
Study 21703594 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic lecture
Number of subjects: 60
Study 21703594 — intervention group
Group type: EXPERIMENTAL
Intervention: Second Life
Number of subjects: 60
Study 21703594 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated operating suite
Number of subjects: 60
Study 21703594 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 20852176 — intervention group
Group type: EXPERIMENTAL
Intervention: SMOFlipid 20%
Number of subjects: 28
Study 20852176 — intervention group
Group type: COMPARATOR
Intervention: SOE (Intralipid 20%)
Number of subjects: 28
Study 17432643 — intervention group
Group type: EXPERIMENTAL
Intervention: Deeply needling Ciliao (BL 32) plus routine acupoints
Number of subjects: 180
Study 17432643 — intervention group
Group type: COMPARATOR
Intervention: Routine acupoints only
Number of subjects: 180
Study 15692120 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg
Number of subjects: 642
Study 15692120 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 642
Study 15692120 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 642
Study 15692120 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT >1 mm after mean follow-up of 46 months
Number of subjects: 642
Study 11820420 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutter valve drainage bag
Number of subjects: 50
Study 11820420 — intervention group
Group type: COMPARATOR
Intervention: Conventional underwater seal system
Number of subjects: 50
Study 9564295 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich group (fibrin glue sandwich technique)
Number of subjects: 111
Study 9564295 — intervention group
Group type: COMPARATOR
Intervention: Sealing group (fibrin glue sealing technique)
Number of subjects: 111
Study 9564295 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich group (fibrin glue sandwich technique) for gastric malignancy patients
Number of subjects: 111
Study 9564295 — intervention group
Group type: COMPARATOR
Intervention: Sealing group (fibrin glue sealing technique) for gastric malignancy patients
Number of subjects: 111
Study 8042889 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management intervention with educational materials and follow-up calls within 24 hours of discharge.
Number of subjects: 668
Study 8042889 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without case management intervention).
Number of subjects: 668
Study 3113245 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms four times daily for seven days)
Number of subjects: 45
Study 3113245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 3113245 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 45
Study 3113245 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol vs Placebo
Number of subjects: 45
Study 31407414 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (IMIQ)
Number of subjects: 479
Study 31407414 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 3% gel (DIC)
Number of subjects: 479
Study 28792791 — intervention group
Group type: EXPERIMENTAL
Intervention: JoyBar control
Number of subjects: 27
Study 28792791 — intervention group
Group type: COMPARATOR
Intervention: Standard joystick control
Number of subjects: 27
Study 26840968 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside teaching rounds
Number of subjects: 107
Study 26840968 — intervention group
Group type: COMPARATOR
Intervention: Nonbedside teaching rounds
Number of subjects: 107
Study 24956324 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based community health worker (CHW) delivered diabetes self-management intervention
Number of subjects: 287
Study 24956324 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 287
Study 23889940 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO(4) 70 mg/kg
Number of subjects: 56
Study 23889940 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 56
Study 21564049 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath(®) videolaryngoscope
Number of subjects: 80
Study 21564049 — intervention group
Group type: COMPARATOR
Intervention: Henderson straight blade laryngoscope
Number of subjects: 80
Study 19231315 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg/day)
Number of subjects: 8888
Study 19231315 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (20 to 40 mg/day)
Number of subjects: 8888
Study 16805922 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-adrenomedullin (proADM) levels
Number of subjects: 302
Study 16805922 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-adrenomedullin (proADM)
Number of subjects: 302
Study 16805922 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical model including PSI and proADM
Number of subjects: 302
Study 12812657 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg and letrozole (2.5 mg) orally q.d. for 8 weeks
Number of subjects: 191
Study 12812657 — intervention group
Group type: COMPARATOR
Intervention: Letrozole 2.5 mg and exemestane (25 mg) orally q.d. for 8 weeks
Number of subjects: 191
Study 10997396 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiretroviral therapy
Number of subjects: 26
Study 10997396 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antiretroviral therapy
Number of subjects: 26
Study 10997396 — intervention group
Group type: COMPARATOR
Intervention: Both double and triple therapies
Number of subjects: 26
Study 9051062 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month regimen (4S3H3R3Z3/2H3R3)
Number of subjects: 91
Study 9051062 — intervention group
Group type: COMPARATOR
Intervention: 9-month regimen (4S3H3R3Z3/5H3R3)
Number of subjects: 91
Study 8159300 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin (CsA) 5 mg/kg/day in adults, 6 mg/kg/day in children for 9 months, tapered off by 25% every month until complete discontinuation at month 12
Number of subjects: 66
Study 8159300 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide 2.5 mg/kg/day for 8 weeks
Number of subjects: 66
Study 6689183 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine
Number of subjects: 8
Study 31188421 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein-First Surgical Technique
Number of subjects: 86
Study 31188421 — intervention group
Group type: COMPARATOR
Intervention: Artery-First Surgical Technique
Number of subjects: 86
Study 29579042 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine treatment (multiple doses over 6 weeks)
Number of subjects: 457
Study 26645793 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Personalized Diabetes Management (PDM)
Number of subjects: 1014
Study 26645793 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 1014
Study 25049132 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei subsp paracasei L. casei W8 (10^9 CFU)
Number of subjects: 21
Study 25049132 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei subsp paracasei L. casei W8 (10^10 CFU)
Number of subjects: 21
Study 25049132 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 21
Study 23138078 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home monitoring intervention via broadband communication device with care coordinator nurse
Number of subjects: 0
Study 23138078 — intervention group
Group type: COMPARATOR
Intervention: Usual care from GP
Number of subjects: 0
Study 21129226 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition and physical activity intervention
Number of subjects: 600
Study 21129226 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 600
Study 17610346 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management of oral anticoagulant therapy (including a teaching program for self-management followed by 6 months of independent self-management)
Number of subjects: 92
Study 17610346 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (6 months of standard care)
Number of subjects: 92
Study 16944823 — intervention group
Group type: EXPERIMENTAL
Intervention: Positioning procedure (two 30-min sessions a day, five days a week, for five weeks)
Number of subjects: 19
Study 15250178 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple presentations of phonological associates (1, 2, or 3 times) during study in Experiment 1
Number of subjects: 0
Study 15250178 — intervention group
Group type: EXPERIMENTAL
Intervention: Five repetitions of phonological associates during study in Experiment 2
Number of subjects: 0
Study 15250178 — intervention group
Group type: EXPERIMENTAL
Intervention: Two study presentations of critical test words in Experiment 2
Number of subjects: 0
Study 15250178 — intervention group
Group type: COMPARATOR
Intervention: Control lures (not specified in detail)
Number of subjects: 0
Study 11013363 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-cm excision margin
Number of subjects: 989
Study 11013363 — intervention group
Group type: COMPARATOR
Intervention: 5-cm excision margin
Number of subjects: 989
Study 9001829 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin
Number of subjects: 1108
Study 9001829 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 1108
Study 1518313 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric consultation letter
Number of subjects: 73
Study 1518313 — intervention group
Group type: COMPARATOR
Intervention: No consultation
Number of subjects: 73
Study 6828828 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation programme including diet therapy
Number of subjects: 133
Study 6828828 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 133
Study 26823382 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed-Forward Modeling (FFM) system
Number of subjects: 0
Study 26823382 — intervention group
Group type: COMPARATOR
Intervention: Nonpharmacological community care intervention
Number of subjects: 0
Study 31352180 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious games intervention (12 supervised sessions, 45 minutes each) aimed at improving the most affected upper limb.
Number of subjects: 18
Study 27858685 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT), applied once a week for three weeks
Number of subjects: 60
Study 27858685 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 60
Study 27858685 — intervention group
Group type: COMPARATOR
Intervention: Placebo Taping
Number of subjects: 60
Study 25196239 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week group intervention 'Living Well with Dementia'
Number of subjects: 58
Study 25196239 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (treatment as usual)
Number of subjects: 58
Study 24060951 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics preparation for one month
Number of subjects: 16
Study 24060951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22185091 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic technique for PD catheter insertion
Number of subjects: 0
Study 22185091 — intervention group
Group type: COMPARATOR
Intervention: Open technique for PD catheter insertion
Number of subjects: 0
Study 19101098 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone dose increase (100mg/day) with split contingency
Number of subjects: 252
Study 19101098 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone dose increase (70mg/day) with split contingency
Number of subjects: 252
Study 19101098 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent control group (100mg/day)
Number of subjects: 252
Study 19101098 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent on cocaine-negative urines
Number of subjects: 252
Study 19101098 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment during 5-week baseline
Number of subjects: 252
Study 19101098 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention groups
Number of subjects: 252
Study 17345784 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg/day)
Number of subjects: 188
Study 17345784 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (150 mg/day)
Number of subjects: 188
Study 17345784 — intervention group
Group type: COMPARATOR
Intervention: Control (Rosiglitazone 4 mg/day)
Number of subjects: 188
Study 14659863 — intervention group
Group type: EXPERIMENTAL
Intervention: GP IIb/IIIa inhibitors (abciximab) administered intravenously, along with heparin and aspirin during failed thrombolysis or after effective thrombolysis due to pain recurrence and ST segment elevation.
Number of subjects: 84
Study 14659863 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered with full dose of rtpA (100 mg) and standard heparin treatment and aspirin during failed thrombolysis or after effective thrombolysis due to pain recurrence and ST segment elevation.
Number of subjects: 84
Study 14659863 — intervention group
Group type: EXPERIMENTAL
Intervention: GP IIb/IIIa inhibitors (abciximab)
Number of subjects: 84
Study 14659863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 10780137 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 21
Study 10780137 — intervention group
Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 21
Study 9265549 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater involvement in care (experimental group)
Number of subjects: 31
Study 9265549 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 31
Study 1458389 — intervention group
Group type: EXPERIMENTAL
Intervention: NG decompression
Number of subjects: 102
Study 1458389 — intervention group
Group type: COMPARATOR
Intervention: No NG decompression
Number of subjects: 102
Study 6485854 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg glucagon/kg body weight intramuscularly before attempts at reduction
Number of subjects: 188
Study 6485854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no glucagon before reduction attempts)
Number of subjects: 188
Study 6485854 — intervention group
Group type: COMPARATOR
Intervention: Control group (after 3 unsuccessful attempts)
Number of subjects: 188
Study 31671592 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel smartphone application accessed weekly from week 1 to week 6
Number of subjects: 8
Study 31671592 — intervention group
Group type: COMPARATOR
Intervention: Control group accessed the application after week 6
Number of subjects: 8
Study 30462806 — intervention group
Group type: EXPERIMENTAL
Intervention: sHT-Tr (exercise training group)
Number of subjects: 20
Study 30462806 — intervention group
Group type: COMPARATOR
Intervention: sHT-Sed (control group)
Number of subjects: 20
Study 26687391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m², once every 21 days) plus best supportive care
Number of subjects: 148
Study 26687391 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 148
Study 26687391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed group
Number of subjects: 148
Study 26687391 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 148
Study 25180609 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L polyethylene glycol plus ascorbate (PEG+Asc)
Number of subjects: 356
Study 25180609 — intervention group
Group type: COMPARATOR
Intervention: Sodium phosphate (NaP)
Number of subjects: 356
Study 22663197 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-simulating liquid (FSL) - citric acid
Number of subjects: 6
Study 22663197 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-simulating liquid (FSL) - ethanol
Number of subjects: 6
Study 22663197 — intervention group
Group type: COMPARATOR
Intervention: Control group (air)
Number of subjects: 6
Study 21306085 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri supplementation (containing L. reuteri, ATCC 55730 and ATCC PTA 5289) for 12 weeks
Number of subjects: 23
Study 21306085 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 23
Study 17437874 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% propolis solution
Number of subjects: 0
Study 17437874 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% propolis solution
Number of subjects: 0
Study 17437874 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-shelf life light milk
Number of subjects: 0
Study 17437874 — intervention group
Group type: EXPERIMENTAL
Intervention: Hank's Balanced Salt Solution
Number of subjects: 0
Study 17437874 — intervention group
Group type: COMPARATOR
Intervention: Tap water (negative control)
Number of subjects: 0
Study 17437874 — intervention group
Group type: COMPARATOR
Intervention: DMEM (positive control)
Number of subjects: 0
Study 15820998 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 864
Study 15820998 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 864
Study 11434589 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral PEG 4000 treatment
Number of subjects: 12
Study 11434589 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal instillation of PEG 4000
Number of subjects: 12
Study 9757919 — intervention group
Group type: EXPERIMENTAL
Intervention: pHi-guided therapy
Number of subjects: 55
Study 9757919 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 55
Study 8141282 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) during insulin clamp
Number of subjects: 7
Study 8141282 — intervention group
Group type: COMPARATOR
Intervention: Control study (no LBNP) during insulin clamp
Number of subjects: 7
Study 3202416 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled metaproterenol
Number of subjects: 10
Study 3202416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30260780 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy added to sedation
Number of subjects: 0
Study 30260780 — intervention group
Group type: COMPARATOR
Intervention: No music treatment (control group)
Number of subjects: 0
Study 27790965 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice cochlear implant surgery on different specimens for four weeks
Number of subjects: 11
Study 27790965 — intervention group
Group type: COMPARATOR
Intervention: Practice cochlear implant surgery on the same specimen for four weeks
Number of subjects: 11
Study 26574755 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (SB) 0.3 g∙kg‐1BM
Number of subjects: 15
Study 26574755 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study 23519431 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased number of trajectory changes
Number of subjects: 0
Study 23519431 — intervention group
Group type: COMPARATOR
Intervention: Spatial proximity controlled
Number of subjects: 0
Study 20595158 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment with heated humidification
Number of subjects: 20
Study 20595158 — intervention group
Group type: COMPARATOR
Intervention: CPAP treatment with sham‐heated humidification
Number of subjects: 20
Study 18294230 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine powder air-polishing (GPAP)
Number of subjects: 10